Cell therapy with bone marrow cells for myocardial regeneration

Antioxidants and Redox Signaling

Volumn 11, Issue 8, 2009, Pages 1897-1911

  Kim, Hyongbum ^a   Kim, Sung Whan ^a   Nam, Douglas ^a   Kim, Sinae ^a   Yoon, Young Sup ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE;

ANGIOGENESIS; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL FUSION; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; COCULTURE; ENDOTHELIAL STEM CELL; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE REGENERATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMORAL IMMUNITY; ISCHEMIC HEART DISEASE; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; MUSCLE REGENERATION; NONHUMAN; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PHENOTYPIC VARIATION; PRIORITY JOURNAL; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION;

ANIMALS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MYOCARDIAL INFARCTION; REGENERATION;

EID: 67650272686     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2009.2486     Document Type: Review

References (119)

1. Abbate A, Bussani R, Biondi-Zoccai GG, Rossiello R, Sil- vestri F, Baldi F, Biasucci LM, and Baldi A. Persistent infarct- related artery occlusion is associated with an increased myocardial apoptosis at postmortem examination in humans late after an acute myocardial infarction. Circulation 106: 1051-1054, 2002.
2. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM, Fike JR, Lee HO, Pfeffer K, Lois C, Morrison SJ, and Alvarez-Buylla A. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425: 968-973, 2003.
3. Amado LC, Saliaris AP, Schuleri KH, St John M, Xie JS, Cattaneo S, Durand DJ, Fitton T, Kuang JQ, Stewart G, Lehrke S, Baumgartner WW, Martin BJ, Heldman AW, and Hare JM. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad SciUS A 102: 11474-11479, 2005.
4. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, and Isner JM. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85: 221-228, 1999.
5. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, and Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967, 1997.
6. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, and Isner JM. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18:3964-3972, 1999.
7. Atkins BZ, Hueman MT, Meuchel J, Hutcheson KA, Glower DD, and Taylor DA. Cellular cardiomyoplasty improves diastolic properties of injured heart. J Surg Res 85:234-242, 1999.
8. Badorff C, Brandes RP, Popp R, Rupp S, Urbich C, Aicher A, Fleming I, Busse R, Zeiher AM, and Dimmeler S. Transdifferentiation of blood-derived human adult endo- thelial progenitor cells into functionally active cardiomyo-cytes. Circulation 107: 1024-1032, 2003.
9. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weiss- man IL, and Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428: 668-673, 2004.
10. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K, Leri A, Kajstura J, Nadal-Ginard B, and Anversa P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114: 763-776, 2003.
11. Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R, Nadal-Ginard B, Silvestri F, Leri A, Beltrami CA, and Anversa P. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 344: 1750-1757, 2001.
12. Brazelton TR, Rossi FM, Keshet GI, and Blau HM. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290: 1775-1779, 2000.
13. Bussani R, Abbate A, Biondi-Zoccai GG, Dobrina A, Leone AM, Camilot D, Di Marino MP, Baldi F, Silvestri F, Biasucci LM, and Baldi A. Right ventricular dilatation after left ventricular acute myocardial infarction is predictive of extremely high peri-infarctual apoptosis at postmortem examination in humans. J Clin Pathol 56: 672-676, 2003.
14. Carmeliet P and Jain RK. Angiogenesis in cancer and other diseases. Nature 407: 249-257, 2000.
15. Cho HJ, Lee N, Lee JY, Choi YJ, Ii M, Wecker A, Jeong JO, Curry C, Qin G, and Yoon YS. Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart. J Exp Med 204:3257-3269, 2007.
16. Davani S, Marandin A, Mersin N, Royer B, Kantelip B, Herve P, Etievent JP, and Kantelip JP. Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model. Circulation 108(suppl 1): II253-II258, 2003.
17. Etzion S, Battler A, Barbash IM, Cagnano E, Zarin P, Granot Y, Kedes LH, Kloner RA, and Leor J. Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction. J Mol Cell Cardiol 33: 1321-1330, 2001.
18. Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, and Mavilio F. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279: 1528-1530, 1998.
19. Fuchs S, Baffour R, Zhou YF, Shou M, Pierre A, Tio FO, Weissman NJ, Leon MB, Epstein SE, and Kornowski R. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 37: 1726-1732, 2001.
20. Gehling UM, Ergun S, Schumacher U, Wagener C, Pantel K, Otte M, Schuch G, Schafhausen P, Mende T, Kilic N, Kluge K, Schafer B, Hossfeld DK, and Fiedler W. In vitro differentiation of endothelial cells from ac133-positive progenitor cells. Blood 95: 3106-3112, 2000.
21. Goodell MA, Brose K, Paradis G, Conner AS, and Mulligan RC. Isolation and functional properties of murine hemato- poietic stem cells that are replicating in vivo. J Exp Med 183:1797-1806, 1996.
22. Gulati R, Jevremovic D, Peterson TE, Witt TA, Kleppe LS, Mueske CS, Lerman A, Vile RG, and Simari RD. Autologous culture-modified mononuclear cells confer vascular protection after arterial injury. Circulation 108: 1520-1526, 2003.
23. Gussoni E, Soneoka Y, Strickland CD, Buzney EA, Khan MK, Flint AF, Kunkel LM, and Mulligan RC. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401: 390-394, 1999.
24. Hakuno D, Fukuda K, Makino S, Konishi F, Tomita Y, Manabe T, Suzuki Y, Umezawa A, and Ogawa S. Bone marrow-derived regenerated cardiomyocytes (cmg cells) express functional adrenergic and muscarinic receptors. Circulation 105: 380-386, 2002.
25. Harris RG, Herzog EL, Bruscia EM, Grove JE, Van Arnam JS, and Krause DS. Lack of a fusion requirement for development of bone marrow-derived epithelia. Science 305:90-93, 2004.
26. Hierlihy AM, Seale P, Lobe CG, Rudnicki MA, and Megeney LA. The post-natal heart contains a myocardial stem cell population. FEBS Lett 530: 239-243, 2002.
27. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK, Oh BH, Lee MM, and Park YB. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 24:288-293, 2004.
28. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, Pollok K, Ferkowicz MJ, Gilley D, and Yoder MC. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104: 2752-2760, 2004.
29. Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ, Majesky MW, Entman ML, Michael LH, Hirschi KK, and Goodell MA. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107:1395-1402, 2001.
30. Jain M, DerSimonian H, Brenner DA, Ngoy S, Teller P, Edge AS, Zawadzka A, Wetzel K, Sawyer DB, Colucci WS, Ap-stein CS, and Liao R. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation 103:1920-1927,2001.
31. Jang YY, Collector MI, Baylin SB, Diehl AM, and Sharkis SJ. Hematopoietic stem cells convert into liver cells within days without fusion. Nat Cell Biol 6: 532-539, 2004.
32. Jaquet K, Krause KT, Denschel J, Faessler P, Nauerz M, Geidel S, Boczor S, Lange C, Stute N, Zander A, and Kuck KH. Reduction of myocardial scar size after implantation of mesenchymal stem cells in rats: what is the mechanism? Stem Cells Dev 14: 299-309, 2005.
33. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Lar-gaespada DA, and Verfaillie CM. Pluripotency of mesen- chymal stem cells derived from adult marrow. Nature 418:41-49, 2002.
34. Johansson CB, Youssef S, Koleckar K, Holbrook C, Doyonnas R, Corbel SY, Steinman L, Rossi FM, and Blau HM. Extensive fusion of haematopoietic cells with Purkinje neurons in response to chronic inflammation. Nat Cell Biol 10: 575-583, 2008.
35. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, and Asahara T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 97:3422-3427, 2000.
36. Kamihata H, Matsubara H, Nishiue T, Fujiyama S, Tsut- sumi Y, Ozono R, Masaki H, Mori Y, Iba O, Tateishi E, Kosaki A, Shintani S, Murohara T, Imaizumi T, and Iwa- saka T. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104: 1046-1052, 2001.
37. Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchida S, Masuda H, Silver M, Ma H, Kearney M, Isner JM, and Asahara T. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103: 634-637, 2001.
38. Kawamoto A, Tkebuchava T, Yamaguchi J, Nishimura H, Yoon YS, Milliken C, Uchida S, Masuo O, Iwaguro H, Ma H, Hanley A, Silver M, Kearney M, Losordo DW, Isner JM, and Asahara T. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovasculariza- tion of myocardial ischemia. Circulation 107: 461-68, 2003.
39. Kinnaird T, Stabile E, Burnett MS, and Epstein SE. Bone- marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences. Circ Res 95: 354-363, 2004.
40. Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S, and Epstein SE. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94: 678-685, 2004.
41. Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, Barr S, Fuchs S, and Epstein SE. Local delivery of marrow-derived stromal cells augments collateral perfusion through para- crine mechanisms. Circulation 109: 1543-1549, 2004.
42. Kobayashi T, Hamano K, Li TS, Katoh T, Kobayashi S, Matsuzaki M, and Esato K. Enhancement of angiogenesis by the implantation of self bone marrow cells in a rat is-chemic heart model. J Surg Res 89: 189-195, 2000.
43. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkh-off D, Wang J, Homma S, Edwards NM, and Itescu S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7: 430-436, 2001.
44. Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, Gardner R, Neutzel S, and Sharkis SJ. Multi-organ, multi- lineage engraftment by a single bone marrow-derived stem cell. Cell 105: 369-377, 2001.
45. LaBarge MA and Blau HM. Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell 111:589-601, 2002.
46. Laflamme MA, Myerson D, Saffitz JE, and Murry CE. Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ Res 90: 634-640, 2002.
47. Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, Dohse M, Osborne L, Wang X, Finegold M, Weissman IL, and Grompe M. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 6: 1229-1234, 2000.
48. Laugwitz KL, Moretti A, Lam J, Gruber P, Chen Y, Woo- dard S, Lin LZ, Cai CL, Lu MM, Reth M, Platoshyn O, Yuan JX, Evans S, and Chien KR. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433: 647-653, 2005.
49. Lee N, Thorne T, Losordo DW, and Yoon YS. Repair of ischemic heart disease with novel bone marrow-derived multipotent stem cells. Cell Cycle 4: 861-864, 2005.
50. Leobon B, Garcin I, Menasche P, Vilquin JT, Audinat E, and Charpak S. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci U S A 100: 7808-7811, 2003.
51. Leor J, Patterson M, Quinones MJ, Kedes LH, and Kloner RA. Transplantation of fetal myocardial tissue into the in- farcted myocardium of rat: a potential method for repair of infarcted myocardium? Circulation 94: II332-II336, 1996.
52. Li RK, Jia ZQ, Weisel RD, Mickle DA, Zhang J, Mohabeer MK, Rao V, and Ivanov J. Cardiomyocyte transplantation improves heart function. Ann Thorac Surg 62: 654-660, discussion 660-651, 1996.
53. Lin Y, Weisdorf DJ, Solovey A, and Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105: 71-77, 2000.
54. Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, Sano M, Takahashi T, Hori S, Abe H, Hata J, Umezawa A, and Ogawa S. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103: 697-705, 1999.
55. Martin-Rendon E, Brunskill SJ, Hyde CJ, Stanworth SJ, Mathur A, and Watt SM. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J 29: 1807-1818, 2008.
56. Menasche P, Alfieri O, Janssens S, McKenna W, Reich- enspurner H, Trinquart L, Vilquin JT, Marolleau JP, Seymour B, Larghero J, Lake S, Chatellier G, Solomon S, Desnos M, and Hagege AA. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 117: 1189-1200, 2008.
57. Mezey E, Chandross KJ, Harta G, Maki RA, and McKercher SR. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 290:1779-1782, 2000.
58. Minami E, Laflamme MA, Saffitz JE, and Murry CE. Ex- tracardiac progenitor cells repopulate most major cell types in the transplanted human heart. Circulation 112: 2951-2958, 2005.
59. Mishra PK. Bone marrow-derived mesenchymal stem cells for treatment of heart failure: is it all paracrine actions and immunomodulation? J Cardiovasc Med (Hagerstown) 9: 122-128, 2008.
60. Muller-Ehmsen J, Peterson KL, Kedes L, Whittaker P, Dow JS, Long TI, Laird PW, and Kloner RA. Rebuilding a damaged heart: long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function. Circulation 105: 1720-1726, 2002.
61. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, Eguchi H, Onitsuka I, Matsui K, and Imaizumi T. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. JClinInvest105: 1527-1536, 2000.
62. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Naka- jima HO, Rubart M, Pasumarthi KB, Virag JI, Bartelmez SH, Poppa V, Bradford G, Dowell JD, Williams DA, and Field LJ. Haematopoietic stem cells do not transdiffer- entiate into cardiac myocytes in myocardial infarcts. Nature 428: 664-668, 2004.
63. Murry CE, Wiseman RW, Schwartz SM, and Hauschka SD. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest 98: 2512-2523, 1996.
64. Nygren JM, Jovinge S, Breitbach M, Sawen P, Roll W, Hescheler J, Taneera J, Fleischmann BK, and Jacobsen SE. Bone marrow-derived hematopoietic cells generate cardio- myocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 10: 494-501, 2004.
65. Nygren JM, Liuba K, Breitbach M, Stott S, Thoren L, Roell W, Geisen C, Sasse P, Kirik D, Bjorklund A, Nerlov C, Fleischmann BK, Jovinge S, and Jacobsen SE. Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion. Nat Cell Biol 10: 584-592, 2008.
66. O'Neill TJT, Wamhoff BR, Owens GK, and Skalak TC. Mobilization of bone marrow-derived cells enhances the angiogenic response to hypoxia without transdifferentia-tion into endothelial cells. Circ Res 97: 1027-1035, 2005.
67. Oh H, Bradfute SB, Gallardo TD, Nakamura T, Gaussin V, Mishina Y, Pocius J, Michael LH, Behringer RR, Garry DJ, Entman ML, and Schneider MD. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A 100: 12313-12318, 2003.
68. Orlic D, Fischer R, Nishikawa S, Nienhuis AW, and Bodine DM. Purification and characterization of heterogeneous pluripotent hematopoietic stem cell populations expressing high levels of c-kit receptor. Blood 82: 762-770, 1993.
69. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, and Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature 410: 701-705, 2001.
70. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, Nadal-Ginard B, Bodine DM, Leri A, and An- versa P. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 98: 10344-10349, 2001.
71. Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, Netoff TI, and Taylor DA. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 14: 213-221, 2008.
72. Oyama T, Nagai T, Wada H, Naito AT, Matsuura K, Iwa-naga K, Takahashi T, Goto M, Mikami Y, Yasuda N, Aka- zawa H, Uezumi A, Takeda S, and Komuro I. Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo. J Cell Biol 176: 329-341, 2007.
73. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, and Rafii S. Expression of vegfr-2 and ac133 by circulating human cd34(+) cells identifies a population of functional endo-thelial precursors. Blood 95: 952-958, 2000.
74. Pelacho B, Nakamura Y, Zhang J, Ross J, Heremans Y, Nelson-Holte M, Lemke B, Hagenbrock J, Jiang Y, Prosper F, Luttun A, and Verfaillie CM. Multipotent adult progenitor cell transplantation increases vascularity and improves left ventricular function after myocardial infarction. J Tissue Eng Regen Med 1: 51-59, 2007.
75. Peters BA, Diaz LA, Polyak K, Meszler L, Romans K, Guinan EC, Antin JH, Myerson D, Hamilton SR, Vogelstein B, Kinzler KW, and Lengauer C. Contribution of bone marrow-derived endothelial cells to human tumor vascu-lature. Nat Med 11: 261-262, 2005.
76. Pfeffer MA and Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation 81: 1161-1172, 1990.
77. Pfister O, Mouquet F, Jain M, Summer R, Helmes M, Fine A, Colucci WS, and Liao R. Cd31 but not Cd31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ Res 97: 52-61, 2005.
78. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, and Marshak DR. Multilineage potential of adult human mes- enchymal stem cells. Science 284: 143-147, 1999.
79. Quaini F, Urbanek K, Beltrami AP, Finato N, Beltrami CA, Nadal-Ginard B, Kajstura J, Leri A, and Anversa P. Chi- merism of the transplanted heart. N Engl J Med 346: 5-15, 2002.
80. Rehman J, Li J, Orschell CM, and March KL. Peripheral blood ''endothelial progenitor cells'' are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107: 1164-1169, 2003.
81. Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, and Verfaillie CM. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 109: 337-346, 2002.
82. Reyes M, Lund T, Lenvik T, Aguiar D, Koodie L, and Verfaillie CM. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 98: 2615-2625, 2001.
83. Risau W and Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol 11: 73-91, 1995.
84. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, and Hong Y. Heart Disease and Stroke Statistics: 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117: e25-e146, 2008.
85. Rosenzweig A. Cardiac cell therapy: mixed results from mixed cells. N Engl J Med 355: 1274-1277, 2006.
86. Rubart M, Pasumarthi KB, Nakajima H, Soonpaa MH, Nakajima HO, and Field LJ. Physiological coupling of donor and host cardiomyocytes after cellular transplantation. Circ Res 92: 1217-1224, 2003.
87. Sadanandan S and Hochman JS. Early reperfusion, late reperfusion, and the open artery hypothesis: an overview. Prog Cardiovasc Dis 42: 397-404, 2000.
88. Schmeisser A, Garlichs CD, Zhang H, Eskafi S, Graffy C, Ludwig J, Strasser RH, and Daniel WG. Monocytes coex- press endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions. Cardiovasc Res 49: 671-680, 2001.
89. Schwartz RE, Reyes M, Koodie L, Jiang Y, Blackstad M, Lund T, Lenvik T, Johnson S, Hu WS, and Verfaillie CM. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest 109: 1291-1302, 2002.
90. Scorsin M, Hagege A, Vilquin JT, Fiszman M, Marotte F, Samuel JL, Rappaport L, Schwartz K, and Menasche P. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Cardiovasc Surg 119: 1169-1175, 2000.
91. Shake JG, Gruber PJ, Baumgartner WA, Senechal G, Meyers J, Redmond JM, Pittenger MF, and Martin BJ. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg 73: 1919-1925; discussion 1926, 2002.
92. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A, Fujita Y, Kothari S, Mohle R, Sauvage LR, Moore MA, Storb RF, and Hammond WP. Evidence for circulating bone marrow- derived endothelial cells. Blood 92: 362-367, 1998.
93. Shintani S, Murohara T, Ikeda H, Ueno T, Sasaki K, Duan J, and Imaizumi T. Augmentation of postnatal neovascular- ization with autologous bone marrow transplantation. Circulation 103: 897-903, 2001.
94. Silva GV, Litovsky S, Assad JA, Sousa AL, Martin BJ, Vela D, Coulter SC, Lin J, Ober J, Vaughn WK, Branco RV, Oliveira EM, He R, Geng YJ, Willerson JT, and Perin EC. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 111: 150-156, 2005.
95. Smith A. A glossary for stem-cell biology. Nature 441: 1060, 2006.
96. Takahashi M, Li TS, Suzuki R, Kobayashi T, Ito H, Ikeda Y, Matsuzaki M, and Hamano K. Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury. Am J Physiol Heart Circ Physiol 291:H886-H893, 2006.
97. Tateno K, Minamino T, Toko H, Akazawa H, Shimizu N, Takeda S, Kunieda T, Miyauchi H, Oyama T, Matsuura K, Nishi J, Kobayashi Y, Nagai T, Kuwabara Y, Iwakura Y, Nomura F, Saito Y, and Komuro I. Critical roles of muscle- secreted angiogenic factors in therapeutic neovasculariza-tion. Circ Res 98: 1194-1202, 2006.
98. Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, Hutcheson KA, Glower DD, and Kraus WE. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 4: 929-933, 1998.
99. Terada N, Hamazaki T, Oka M, Hoki M, Mastalerz DM, Nakano Y, Meyer EM, Morel L, Petersen BE, and Scott EW. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416: 542-545, 2002.
100. Toma C, Pittenger MF, Cahill KS, Byrne BJ, and Kessler PD. Human mesenchymal stem cells differentiate to a cardio- myocyte phenotype in the adult murine heart. Circulation 105: 93-98, 2002.
101. Tomita S, Li RK, Weisel RD, Mickle DA, Kim EJ, Sakai T, and Jia ZQ. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100:II247-II256, 1999.
102. Uemura R, Xu M, Ahmad N, and Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 98: 1414-1421, 2006.
103. Urbich C, Heeschen C, Aicher A, Dernbach E, Zeiher AM, and Dimmeler S. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 108: 2511-2516, 2003.
104. van Praag H, Schinder AF, Christie BR, Toni N, Palmer TD, and Gage FH. Functional neurogenesis in the adult hippocampus. Nature 415: 1030-1034, 2002.
105. Vassilopoulos G, Wang PR, and Russell DW. Transplanted bone marrow egenerates liver by cell fusion. Nature 422:901-904, 2003.
106. Walter DH, Haendeler J, Reinhold J, Rochwalsky U, Seeger F, Honold J, Hoffmann J, Urbich C, Lehmann R, Arenzana- Seisdesdos F, Aicher A, Heeschen C, Fichtlscherer S, Zeiher AM, and Dimmeler S. Impaired cxcr4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ Res 97: 1142-1151, 2005.
107. Wang JS, Shum-Tim D, Galipeau J, Chedrawy E, Eliopoulos N, and Chiu RC. Marrow stromal cells for cellular cardio- myoplasty: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg 120: 999-1005, 2000.
108. Wang X, Willenbring H, Akkari Y, Torimaru Y, Foster M, Al-Dhalimy M, Lagasse E, Finegold M, Olson S, and Grompe M. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 422: 897-901, 2003.
109. World Health Organization. The World Health Report 2007 [online]. World Health Organization. http://www.who.int/ whr/2007/en/index.html 2008, Jun. 6.
110. Yamahara K, Fukushima S, Coppen SR, Felkin LE, Varela- Carver A, Barton PJ, Yacoub MH, and Suzuki K. Hetero- geneic nature of adult cardiac side population cells. Biochem Biophys Res Commun 371: 615-620, 2008.
111. Yeh ET. Crp as a mediator of disease. Circulation 109: II11-II14, 2004.
112. Yeh ET, Zhang S, Wu HD, Korbling M, Willerson JT, and Estrov Z. Transdifferentiation of human peripheral blood cd34+-enriched cell population into cardiomyocytes, en- dothelial cells, and smooth muscle cells in vivo. Circulation 108: 2070-2073, 2003.
113. Ying QL, Nichols J, Evans EP, and Smith AG. Changing potency by spontaneous fusion. Nature 416: 545-548, 2002.
114. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, Krasich R, Temm CJ, Prchal JT, and Ingram DA. Redefining endothelial progenitor cells via clonal analysis and hema- topoietic stem/progenitor cell principals. Blood 109: 1801-1809, 2007.
115. Yoon CH, Hur J, Park KW, Kim JH, Lee CS, Oh IY, Kim TY, Cho HJ, Kang HJ, Chae IH, Yang HK, Oh BH, Park YB, and Kim HS. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cyto- kines and matrix metalloproteinases. Circulation 112: 1618-1627, 2005.
116. Yoon YS, Park JS, Tkebuchava T, Luedeman C, and Lo- sordo DW. Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation 109: 3154-3157, 2004.
117. Yoon YS, Wecker A, Heyd L, Park JS, Tkebuchava T, Kusano K, Hanley A, Scadova H, Qin G, Cha DH, Johnson KL, Aikawa R, Asahara T, and Losordo DW. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J ClinInvest 115: 326-338, 2005.
118. Ziegelhoeffer T, Fernandez B, Kostin S, Heil M, Voswinckel R, Helisch A, and Schaper W. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res 94: 230-238, 2004.
119. Zimmermann WH, Melnychenko I, Wasmeier G, Didie M, Naito H, Nixdorff U, Hess A, Budinsky L, Brune K, Michaelis B, Dhein S, Schwoerer A, Ehmke H, and Es- chenhagen T. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 12: 452-458, 2006.